GlassScriptPhysician profile
Michael S Nillas
NPI 1649282658
$2,725.89
in general payments reported to CMS, 2019-2025
20 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $79.00 · 2021: $56.98 · 2022: $360 · 2023: $647 · 2024: $753 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,913 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.00 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $561.65 | 2023-2025 | Optimizer, Optimizer |
| Boston Scientific Corporation | $365.54 | 2019-2024 | Watchman Flx |
| Medtronic, INC. | $310.13 | 2021-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $276.76 | 2023-2025 | Mitraclip, Triclip |
| Atricure, INC. | $147.58 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $147.09 | 2022-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $137.77 | 2024 | Camzyos, Eliquis |
| Inari Medical, INC. | $131.82 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $127.34 | 2025 | Wegovy, Ozempic |
| Pfizer INC. | $115.54 | 2019-2024 | |
| Medtronic Vascular, INC. | $82.51 | 2019 | |
| Amgen INC. | $80.92 | 2024-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $73.90 | 2023-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $54.96 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.26 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $20.33 | 2025 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $18.05 | 2025 | Event |
| Lexicon Pharmaceuticals, INC. | $16.96 | 2024 | |
| Scpharmaceuticals INC. | $16.72 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $15.06 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nillas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.